July 24, 2015

Second Quarter 2015 Financial Results

Our strong portfolio drove revenue growth in Q2 with adjusted EPS up 31.7 percent, while our strategic acquisition of Pharmacyclics and robust development pipeline position AbbVie well for the future.
Share to Facebook Share to Twitter Share to Linkedin Email SUBSCRIPTION MANAGEMENT
Our strong portfolio drove revenue growth in Q2 with adjusted EPS up 31.7 percent, while our strategic acquisition of Pharmacyclics and robust development pipeline position AbbVie well for the future. Read the full press release.


AbbVie-Earnings-Q2-2015-Infographic-Story